Luo et al. (17) used bioinformatics to analyze the differences in lipid metabolism-related gene expression between high-risk and non-high-risk NB in the GSE49710 dataset, developing a prognostic model for NB based on lipid metabolism-related genes and demonstrating that GDPD5 can inhibit NB proliferation and migration and may be targeted and inhibited by hsa-miR-592 to inhibit fat synthesis in SH-SY5Y cells. Here, GDPD5 is linked to neuroblastoma.